z-logo
open-access-imgOpen Access
Celecoxib Decreases Gcf Prostaglandin E2 Levels in Chronic Periodontitis Patients
Author(s) -
Athena Papas
Publication year - 2020
Publication title -
hsoa journal of dentistry
Language(s) - English
Resource type - Journals
ISSN - 2473-6783
DOI - 10.24966/dohc-6783/100012
Subject(s) - celecoxib , prostaglandin e2 , scaling and root planing , chronic periodontitis , periodontology , medicine , periodontitis , dentistry , prostaglandin , mediator
Prostaglandin E2 (PGE2) is a key mediator associated with periodontal bone loss. We recently demonstrated (Yen, et al, J Periodontology 79:104, 2008) that adjunctive use of Celecoxib (a COX-2 selective inhibitor) in conjunction with Scaling and Root Planning (SRP) resulted in significant reduction in Pocket Depth (PD) and gain in Clinical Attachment (CAL) in Chronic Periodontitis (CP) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here